Dipharma Francis, a global CDMO and a leading manufacturer of APIs and intermediates for generic and contract manufacturing markets, said that Kalexsyn, Inc., a Michigan corporation acquired in 2018, has been merged into its 100% owner, Dipharma Inc., a Delaware corporation and member of the Dipharma Group, effective January 1, 2022.   The merger represents the last step of Kalexsyn’s integration into the Dipharma Group. That process started on May 17, 2018 with the acquisition of the company, i...